Nurse Practitioner, Adult Health · New York, NY
NPI
1003117136
Since 2010
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
622 W 168th St
New York, NY, 10032
Phone (212) 305-0914
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,707
87 services
Medicare patients, 2024
45
Average age 68
Drug cost, 2024
$526K
681 prescriptions
Company payments, 2025
$1,631
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Calvin K Lee was code 99214 (office e&m - established), 75 times for 39 patients. In total Calvin K Lee billed 87 services in 5 codes, and Medicare paid $8,707.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-04-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 75 | 39 | $98.75 | $7,406 |
By year: 2022 $5,625 for 65 services; 2023 $6,801 for 81 services; 2024 $8,707 for 87 services.
Medicare prescription drug claims, 2024
In 2024, the drug Calvin K Lee prescribed most often to Medicare patients was Tacrolimus, with 82 prescriptions and refills. In total Calvin K Lee wrote 681 Medicare prescriptions that cost $526K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tacrolimus Generic | 82 | 115 | 13 | $5,308 |
| Pantoprazole Sodium Generic | 59 | 77 | Under 11 | $275 |
| Ursodiol Generic | 42 | 65 | Under 11 | $6,945 |
| Xifaxan Rifaximin | 40 | 54 | Under 11 | $171K |
| Mycophenolate Mofetil Generic | 32 | 48 | Under 11 | $1,472 |
| Entecavir Generic | 27 | 27 | Under 11 | $1,599 |
| Ocaliva Obeticholic Acid | 24 | 24 | Under 11 | $231K |
| Mycophenolic Acid Mycophenolate Sodium | 24 | 28 | Under 11 | $3,134 |
| Lactulose Generic | 21 | 21 | Under 11 | $727 |
| Eliquis Apixaban | 17 | 17 | Under 11 | $9,833 |
| Acyclovir Generic | 17 | 17 | Under 11 | $154 |
| Sirolimus Generic | 17 | 27 | Under 11 | $4,743 |
| Emtricitabine-Tenofovir Disop Emtricitabine/Tenofovir (Tdf) | 14 | 14 | Under 11 | $4,185 |
| Valganciclovir Hcl Generic | 14 | 18 | Under 11 | $3,488 |
| Carvedilol Generic | 13 | 31 | Under 11 | $83.43 |
Brand drugs: - claims; generic drugs: 561 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Calvin K Lee $1,631 ($1,631 in general payments such as food, travel and fees) from 11 companies. The largest payer was Madrigal Pharmaceuticals with $676.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 15 | $676 |
| Gilead Sciences, Inc. GILD | 9 | $334 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 12 | $243 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 5 | $163 |
| Mallinckrodt Hospital Products Inc. | 2 | $52.34 |
| Intra-Sana Laboratories | 2 | $42.53 |
| Invivyd Inc IVVD | 1 | $32.69 |
| Abbvie Inc. ABBV | 1 | $31.98 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22.37 |
| Mirum Pharmaceuticals, Inc. MIRM | 1 | $18.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.